Edition:
United States

LifeVantage Corp (LFVN.OQ)

LFVN.OQ on NASDAQ Stock Exchange Capital Market

2.95USD
12:38pm EDT
Change (% chg)

$-0.04 (-1.34%)
Prev Close
$2.99
Open
$3.00
Day's High
$3.00
Day's Low
$2.93
Volume
3,371
Avg. Vol
33,115
52-wk High
$14.63
52-wk Low
$2.93

LFVN.OQ

Chart for LFVN.OQ

About

LifeVantage Corporation is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy... (more)
No analyst recommendations are available for LFVN.OQ.

Overall

Beta: 0.74
Market Cap(Mil.): $42.56
Shares Outstanding(Mil.): 14.23
Dividend: --
Yield (%): --

Financials

  LFVN.OQ Industry Sector
P/E (TTM): 11.79 22.32 41.42
EPS (TTM): 0.25 -- --
ROI: 19.06 12.53 63.99
ROE: 34.08 15.92 75.97

BRIEF-Lifevantage appoints Steven Fife as CFO

* Lifevantage corp - Appointment of Steven R. Fife as its chief financial officer, effective immediately - SEC filing Source text for Eikon: Further company coverage:

Mar 13 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $133.51 +0.88
AstraZeneca plc (AZN.L) 4,418.00 -29.00
Prestige Brands Holdings, Inc. (PBH.N) $50.76 +0.19
Pfizer Inc. (PFE.N) $32.75 +0.08
Novartis AG (NOVN.S) CHF79.95 +0.15
Merck & Co., Inc. (MRK.N) $61.94 +0.45
Roche Holding Ltd. (ROG.S) CHF240.40 -1.00
Roche Holding Ltd. (RO.S) CHF244.20 -0.30
Abbott Laboratories (ABT.N) $48.73 -0.01

Earnings vs. Estimates